Relatlimab(BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.Relatlimab has a blocking effect, blocking the interaction of LAG-3/MHC II (IC50: 0.67 nM) and LAG-3/FGL1 (IC50: 0.019 nM). Relatlimab is often used with Nivoluma to treat advanced melanoma.
Molecular Weight:
145.2 kDa
Purity:
97.20%
CAS Number:
[1673516-98-7]
Target:
LAG-3
T9901A-001
* VAT and and shipping costs not included. Errors and price changes excepted
